GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
3OF6 | Q6ISU1 | Human pre-T cell receptor crystal structure | |
6BJ2 | Q6IRV4 | TCR589 in complex with HIV(Pol448-456)/HLA-B35 | |
6BJ2 | Q6IRV4 | TCR589 in complex with HIV(Pol448-456)/HLA-B35 | |
7CZW | Q6IPQ0 | S protein of SARS-CoV-2 in complex bound with P5A-2G7 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
5W08 | Q6IPQ0 | A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab | |
5W08 | Q6IPQ0 | A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab | |
5W0D | Q6IPQ0 | Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 | |
5W0D | Q6IPQ0 | Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 | |
6VTU | Q6IPQ0 | DH717.1 Fab monomer in complex with man9 glycan | |
6VTU | Q6IPQ0 | DH717.1 Fab monomer in complex with man9 glycan | |
7D03 | Q6IPQ0 | S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
2K46 | Q6INX3 | Xenopus laevis malectin complexed with nigerose (Glcalpha1-3Glc) | |
2KR2 | Q6INX3 | Xenopus laevis malectin complexed with maltose (Glcalpha1-4Glc) | |
4I0P | Q6ICR9 | HLA-DO in complex with HLA-DM | |
1WAR | Q6IAS6 | Recombinant Human Purple Acid Phosphatase expressed in Pichia Pastoris | |
1WAR | Q6IAS6 | Recombinant Human Purple Acid Phosphatase expressed in Pichia Pastoris | |
2CH5 | Q6IA84 | Crystal structure of human N-acetylglucosamine kinase in complex with N-acetylglucosamine | |
1TI8 | Q6GYW3 | H7 Haemagglutinin | hemagglutinin |
4BSG | Q6GYW3 | Crystal Structure of an H7N3 Avian Influenza Virus Haemagglutinin | |
4BSH | Q6GYW3 | H7N3 Avian Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue 6'-SLN | |
6P91 | Q6GWS0 | Structure of Lassa virus glycoprotein bound to Fab 18.5C | |
6P91 | Q6GWS0 | Structure of Lassa virus glycoprotein bound to Fab 18.5C | |
8EJJ | Q6GWS0 | Lassa virus glycoprotein complex (Josiah) bound to S370.7 Fab | |
7SGD | Q6GWS0 | Lassa virus glycoprotein construct(Josiah GPCysR4) recovered from GPC-I53-50 nanoparticle by localized reconstruction | |
7SGD | Q6GWS0 | Lassa virus glycoprotein construct(Josiah GPCysR4) recovered from GPC-I53-50 nanoparticle by localized reconstruction | |
7SGF | Q6GWS0 | Lassa virus glycoprotein construct (Josiah GPC-I53-50A) in complex with LAVA01 antibody | |
7SGF | Q6GWS0 | Lassa virus glycoprotein construct (Josiah GPC-I53-50A) in complex with LAVA01 antibody | |
2QAD | Q6GMX8 | Structure of tyrosine-sulfated 412d antibody complexed with HIV-1 YU2 gp120 and CD4 | |
7CZR | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
6OGE | Q6GMX6 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
6OGE | Q6GMX6 | Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex | Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Pertuzumab Fab - light chain, Pertuzumab Fab - heavy chain, Trastuzumab Fab - light chain, Trastuzumab Fab - heavy chain |
7CZS | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
6DC5 | Q6GMX6 | RSV prefusion F in complex with AM22 Fab | |
6DC5 | Q6GMX6 | RSV prefusion F in complex with AM22 Fab | |
7D00 | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7D00 | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7CZX | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with P5A-1B9 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7CZX | Q6GMX6 | S protein of SARS-CoV-2 in complex bound with P5A-1B9 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
8BBO | Q6GMX6 | SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab | |
5W6G | Q6GMX4 | Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands | |
5W6G | Q6GMX4 | Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands | |
5VOC | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
8CWK | Q6GMX0 | Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) | |
4YAQ | Q6GMW3 | Crystal structure of a computationally optimized PG9 mutant | |
4YAQ | Q6GMW3 | Crystal structure of a computationally optimized PG9 mutant | |
2PO6 | Q6GMR4 | Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and NKT15 Beta-Chain | |
6VG1 | Q6GLU2 | xenopus protocadherin 8.1 EC1-6 | protocadherin protein |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024